According to the agreement, Laureate will produce Tolera’s TOL101 monoclonal antibody under current good manufacturing practice (cGMP) conditions to be used in clinical trials. John Puisis, president and
Under the terms of the agreement, Exiqon obtains from Roche a non-exclusive license to use SYBR Green I in real time polymerase chain reaction (PCR). SYBR Green provides
Ikonisys said that oncoFISH her2 is a fully automated microscopy application for the determination of HER2 status in human breast cancer specimens processed with Abbott’s PathVysion HER2 DNA
Together, these licenses from the regulatory bodies ensure this facility is ready to support the supply of Bayer’s Kogenate FS/ Kogenate Bayer (antihemophilic factor [recombinant]) line of products
The Phase II trial compared the efficacy and safety of five days of therapy with either 200mg intravenous (IV) peramivir per day, 400mg IV peramivir per day or
In the preclinical study, C-20081 had a 43% increase in plasma half-life compared to linezolid, which might allow for lower overall drug exposure and improved tolerability with a
The data demonstrated that the RGB-286638 small molecule has potent activity against chronic myeloid leukemia (CML) in in vivo models that are resistant to imatinib (Gleevec) and to
The Phase Ib clinical trial is a double-blind, placebo-controlled study that will evaluate the tolerability, pharmacokinetics and viral kinetics of multiple, ascending doses of ANA598 over a period
Two pivotal 12-month studies met their primary endpoints, showing effects on exacerbation rates and pulmonary function (FEV1). Furthermore, two supporting six-month studies confirmed the efficacy of Daxas when
Therapure said that it will apply its experience and knowledge in cell culture and in the design and development of scaled-up biologic manufacturing processes to advance the initial
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.